Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
Clinical trial NCT07446855 · RECRUITING
Trial details
- NCT number
- NCT07446855
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2030-03-29
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.